Published in Cancer Weekly, February 16th, 1998
Dr. Dirk Kieback, Baylor, oversaw the administration of a solution containing the gene-virus combination that is key to the gene therapy.
The adenovirus used in the treatment is an inactivated cold virus that carries a thymidine kinase gene. It reportedly makes the cancer cells susceptible to the anti-viral drug acyclovir, which is used to fight herpes virus infections.
The adenovirus is a very infective organism that takes the thymidine...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (1998-02-16)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.